Seraph® 100 Microbind® utilization in immunocompromised toddler with adenovirus viremia in conjunction with continuous renal replacement therapy and extracorporeal membrane oxygenation
Year: 2025
Type: article
Study design: Case Report
Abstract: The Seraph® 100 Microbind® is an extracorporeal, sorbent hemoperfusion device intended to adsorb pathogens when integrated into extracorporeal circuits. We describe the use of Seraph 100 in an 18-month-old immunocompromised toddler with adenovirus viremia in conjunction with continuous renal replacement therapy and extracorporeal membrane oxygenation.
Source: IDCases
Institutions: Mayo Clinic, Harvard University
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $1,370
OpenAlex ID: W4414417985